Breast cancer progression: insights into multifaceted matrix metalloproteinases. (Q36985012)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17968664 AND SRC:MED&resulttype=core&format=json

9 January 2020

review article

1 reference

title

Breast cancer progression: insights into multifaceted matrix metalloproteinases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17968664 AND SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17968664 AND SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Vincent Chabottaux

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17968664 AND SRC:MED&resulttype=core&format=json

9 January 2020

publication date

30 October 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17968664 AND SRC:MED&resulttype=core&format=json

Clinical & Experimental Metastasis

9 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17968664 AND SRC:MED&resulttype=core&format=json

9 January 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17968664 AND SRC:MED&resulttype=core&format=json

9 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17968664 AND SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

647-656

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17968664 AND SRC:MED&resulttype=core&format=json

Proteomic identification of in vivo substrates for matrix metalloproteinases 2 and 9 reveals a mechanism for resolution of inflammation

9 January 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007/S10585-007-9113-7

Significance of membrane type 1 matrix metalloproteinase expression in breast cancer.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007/S10585-007-9113-7

Matrix metalloproteinases are expressed during ductal and alveolar mammary morphogenesis, and misregulation of stromelysin-1 in transgenic mice induces unscheduled alveolar development

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007/S10585-007-9113-7

CD44 binding through the hemopexin-like domain is critical for its shedding by membrane-type 1 matrix metalloproteinase.

21 January 2018

1 reference

12 December 2020

Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo

1 reference

12 December 2020

Proteolytic imbalance is reversed after therapeutic surgery in breast cancer patients

1 reference

12 December 2020

Gelatinase A expression and localization in human breast cancers. An in situ hybridization study and immunohistochemical detection using confocal microscopy

1 reference

12 December 2020

Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas

1 reference

12 December 2020

Demonstration in vivo that stromelysin-3 functions through its proteolytic activity.

1 reference

12 December 2020

Fibroblast-derived MT1-MMP promotes tumor progression in vitro and in vivo

1 reference

12 December 2020

Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion

1 reference

12 December 2020

Extracellular proteolysis in transgenic mouse models of breast cancer

1 reference

12 December 2020

Serum levels of matrix metalloproteinases MMP-2 and MMP-9 and their tissue natural inhibitors in breast tumors

1 reference

12 December 2020

The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis

1 reference

12 December 2020

Processing of integrin alpha(v) subunit by membrane type 1 matrix metalloproteinase stimulates migration of breast carcinoma cells on vitronectin and enhances tyrosine phosphorylation of focal adhesion kinase

1 reference

12 December 2020

MMP-9 and MMP-2 gelatinases and TIMP-1 and TIMP-2 inhibitors in breast cancer: correlations with prognostic factors

1 reference

12 December 2020

Up-regulation of vascular endothelial growth factor-A by active membrane-type 1 matrix metalloproteinase through activation of Src-tyrosine kinases.

1 reference

12 December 2020

Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1.

1 reference

12 December 2020

Membrane-type 4 matrix metalloproteinase promotes breast cancer growth and metastases

1 reference

12 December 2020

Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis.

1 reference

12 December 2020

Plasma concentration and activity of matrix metalloproteinase 2 and 9 in patients with breast disease, breast cancer and at risk of developing breast cancer.

1 reference

12 December 2020

High levels of TIMP-2 correlate with adverse prognosis in breast cancer.

1 reference

12 December 2020

Transgenic mouse models for the prevention of breast cancer.

1 reference

12 December 2020

[Significance of membrane type-1 matrix metalloproteinase expression in breast cancer]

1 reference

12 December 2020

The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis

1 reference

12 December 2020

Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors

1 reference

12 December 2020

MT1-MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression.

1 reference

12 December 2020

The influence of MMP-14, TIMP-2 and MMP-2 expression on breast cancer prognosis

1 reference

12 December 2020

A molecular signature of metastasis in primary solid tumors

1 reference

12 December 2020

Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas

1 reference

12 December 2020

1 reference

12 December 2020

Anti-Invasive, Antitumoral, and Antiangiogenic Efficacy of a Pyrimidine-2,4,6-trione Derivative, an Orally Active and Selective Matrix Metalloproteinases Inhibitor

1 reference

12 December 2020

Earlier Onset of Tumoral Angiogenesis in Matrix Metalloproteinase-19–Deficient Mice

1 reference

12 December 2020

Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity.

1 reference

12 December 2020

Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix.

1 reference

12 December 2020

Friends or foes - bipolar effects of the tumour stroma in cancer

1 reference

12 December 2020

Protease degradomics: mass spectrometry discovery of protease substrates and the CLIP-CHIP, a dedicated DNA microarray of all human proteases and inhibitors

1 reference

12 December 2020

Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications

1 reference

12 December 2020

From a unique cell to metastasis is a long way to go: clues to stromelysin-3 participation

1 reference

12 December 2020

Matrix metalloproteinases and the regulation of tissue remodelling

1 reference

12 December 2020

The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms

1 reference

12 December 2020

Pro-matrix metalloproteinase-2 transfection increases orthotopic primary growth and experimental metastasis of MDA-MB-231 human breast cancer cells in nude mice

1 reference

12 December 2020

Functional activation of integrin alpha V beta 3 in tumor cells expressing membrane-type 1 matrix metalloproteinase

1 reference

12 December 2020

Discovery of chemokine substrates for matrix metalloproteinases by exosite scanning: a new tool for degradomics

1 reference

12 December 2020

Strategies for MMP inhibition in cancer: innovations for the post-trial era.

1 reference

12 December 2020

Gene expression profiling predicts clinical outcome of breast cancer

1 reference

12 December 2020

Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme

1 reference

12 December 2020

A cancer cell metalloprotease triad regulates the basement membrane transmigration program

1 reference

12 December 2020

Gelatinases (MMP-2 and -9) and their natural inhibitors as prognostic indicators in solid cancers

1 reference

12 December 2020

Metalloproteinases and their inhibitors in tumor angiogenesis

1 reference

12 December 2020

MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover

1 reference

12 December 2020

High cancer cell death in syngeneic tumors developed in host mice deficient for the stromelysin-3 matrix metalloproteinase

1 reference

12 December 2020

The Hallmarks of Cancer

1 reference

12 December 2020

The contribution of bone marrow-derived cells to the tumor vasculature in neuroblastoma is matrix metalloproteinase-9 dependent.

1 reference

12 December 2020

Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry

1 reference

12 December 2020

Fibroblasts in cancer

1 reference

12 December 2020

Matrix metalloproteinases (MMPs) regulate fibrin-invasive activity via MT1-MMP-dependent and -independent processes

1 reference

12 December 2020

Matrix metalloproteinase 26 proteolysis of the NH2-terminal domain of the estrogen receptor beta correlates with the survival of breast cancer patients

1 reference

12 December 2020

Role of pericellular proteolysis by membrane-type 1 matrix metalloproteinase in cancer invasion and angiogenesis

1 reference

12 December 2020

MT-MMP expression and localisation in human lung and breast cancers

1 reference

12 December 2020

The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases.

1 reference

12 December 2020

Tumor-stroma interactions: their role in the control of tumor cell invasion.

1 reference

12 December 2020

Measurement of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMP) in blood and urine: potential clinical applications.

1 reference

12 December 2020

A matrix metalloproteinase expressed on the surface of invasive tumour cells

1 reference

12 December 2020

Matrix metalloproteinase-7 triggers the matricrine action of insulin-like growth factor-II via proteinase activity on insulin-like growth factor binding protein 2 in the extracellular matrix.

1 reference

12 December 2020

Collagenases in cancer

1 reference

12 December 2020

Matrix-dependent proteolysis of surface transglutaminase by membrane-type metalloproteinase regulates cancer cell adhesion and locomotion.

1 reference

12 December 2020

Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy.

1 reference

12 December 2020

Membrane-type metalloproteinases in tumor invasion

1 reference

12 December 2020

MT1-MMP: a tethered collagenase

1 reference

12 December 2020

1 reference

12 December 2020

The Fas counterattack: cancer as a site of immune privilege

1 reference

12 December 2020

Membrane type-matrix metalloproteinases (MT-MMP)

1 reference

12 December 2020

Matrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma

1 reference

12 December 2020

Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability

1 reference

12 December 2020

Reduced angiogenesis and tumor progression in gelatinase A-deficient mice

1 reference

12 December 2020

The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis

1 reference

12 December 2020

Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I

1 reference

12 December 2020

Membrane type-1 matrix metalloproteinase and TIMP-2 in tumor angiogenesis.

1 reference

12 December 2020

Metalloproteinases and their inhibitors in matrix remodeling

1 reference

12 December 2020

Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165

1 reference

12 December 2020

Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3.

1 reference

12 December 2020

Amoeboid shape change and contact guidance: T-lymphocyte crawling through fibrillar collagen is independent of matrix remodeling by MMPs and other proteases

1 reference

12 December 2020

Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration

1 reference

12 December 2020

Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas

1 reference

12 December 2020

Emerging roles of proteases in tumour suppression

1 reference

12 December 2020

Decreased tumor formation in 7,12-dimethylbenzanthracene-treated stromelysin-1 transgenic mice is associated with alterations in mammary epithelial cell apoptosis.

1 reference

12 December 2020

Using genetically engineered mouse models of cancer to aid drug development: an industry perspective

1 reference

12 December 2020

Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion

1 reference

12 December 2020

The role of stroma in breast carcinoma growth in vivo

1 reference

12 December 2020

The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis

1 reference

12 December 2020

Endogenous inhibitors of angiogenesis.

1 reference

12 December 2020

Induction of Cell Migration by Matrix Metalloprotease-2 Cleavage of Laminin-5

1 reference

12 December 2020

Targeting matrilysin and its impact on tumor growth in vivo: the potential implications in breast cancer therapy

1 reference

12 December 2020

Low serum level of pro-matrix metalloproteinase 2 correlates with aggressive behavior in breast carcinoma

1 reference

12 December 2020

Circulating MMP2 and MMP9 in breast cancer -- potential role in classification of patients into low risk, high risk, benign disease and breast cancer categories

1 reference

12 December 2020

New functions for the matrix metalloproteinases in cancer progression

1 reference

12 December 2020

Endothelial tubulogenesis within fibrin gels specifically requires the activity of membrane-type-matrix metalloproteinases (MT-MMPs).

1 reference

12 December 2020

The clinicopathological and prognostic significance of membrane type 1 matrix metalloproteinase (MT1-MMP) and MMP-9 according to their localization in invasive breast carcinoma.

1 reference

12 December 2020

Contribution of MT1-MMP and of human laminin-5 gamma2 chain degradation to mammary epithelial cell migration

1 reference

12 December 2020

Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis.

1 reference

12 December 2020

Identification of insulin-like growth factor-binding protein-1 as a potential physiological substrate for human stromelysin-3

1 reference

12 December 2020

MT1-MMP initiates activation of pro-MMP-2 and integrin alphavbeta3 promotes maturation of MMP-2 in breast carcinoma cells

1 reference

12 December 2020

A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas

1 reference

12 December 2020

Senescent human fibroblasts increase the early growth of xenograft tumors via matrix metalloproteinase secretion

1 reference

12 December 2020

How matrix metalloproteinases regulate cell behavior

1 reference

12 December 2020

Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing

1 reference

12 December 2020

Inhibition of stromal matrix metalloproteases: effects on breast-tumor promotion by fibroblasts.

1 reference

12 December 2020

Mediators of vascular remodelling co-opted for sequential steps in lung metastasis.

1 reference

12 December 2020

Membrane type-matrix metalloproteinases and tumor progression.

1 reference

12 December 2020

Membrane associated proteases and their inhibitors in tumour angiogenesis

1 reference

12 December 2020

Expression of membrane type-1 matrix metalloproteinase, MT1-MMP in human breast cancer and its impact on invasiveness of breast cancer cells.

1 reference

12 December 2020

The influence of matrix metalloproteinase-7 on early mammary tumorigenesis in the multiple intestinal neoplasia mouse.

1 reference

12 December 2020

Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3.

1 reference

12 December 2020

Matrix Metalloproteinase Inhibitors and Cancer--Trials and Tribulations

1 reference

12 December 2020

Altered metastatic behavior of human breast cancer cells after experimental manipulation of matrix metalloproteinase 8 gene expression

1 reference

12 December 2020

Pericellular proteases in angiogenesis and vasculogenesis

1 reference

12 December 2020

Contribution of host MMP-2 and MMP-9 to promote tumor vascularization and invasion of malignant keratinocytes

1 reference

12 December 2020

Dual stromelysin-3 function during natural mouse mammary tumor virus-ras tumor progression

1 reference

12 December 2020

Stromelysin-3 expression promotes tumor take in nude mice

1 reference

12 December 2020

Stromal matrix metalloproteinase-9 regulates the vascular architecture in neuroblastoma by promoting pericyte recruitment

1 reference

12 December 2020

Host microenvironment in breast cancer development: extracellular matrix-stromal cell contribution to neoplastic phenotype of epithelial cells in the breast

1 reference

12 December 2020

Identification of MMP-1 as a putative breast cancer predictive marker by global gene expression analysis.

1 reference

12 December 2020

Protease degradomics: a new challenge for proteomics

1 reference

12 December 2020

Clinical significance of MT1-MMP mRNA expression in breast cancer.

1 reference

12 December 2020

Genes that mediate breast cancer metastasis to lung

1 reference

12 December 2020

Overexpression of membrane-type matrix metalloproteinase-1 gene induces mammary gland abnormalities and adenocarcinoma in transgenic mice

1 reference

12 December 2020

Involvement of Membrane-Type Matrix Metalloproteinases (MT-MMPs) in Capillary Tube Formation by Human Endometrial Microvascular Endothelial Cells: Role of MT3-MMP

1 reference

12 December 2020

Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies.

1 reference

12 December 2020

In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy

1 reference

12 December 2020

Metalloproteinase inhibitors: biological actions and therapeutic opportunities.

1 reference

12 December 2020

Tumstatin, the NC1 domain of alpha3 chain of type IV collagen, is an endogenous inhibitor of pathological angiogenesis and suppresses tumor growth

1 reference

12 December 2020

Metalloproteinases: role in breast carcinogenesis, invasion and metastasis

1 reference

12 December 2020

Fibroblast growth factors, their receptors and signaling

1 reference

12 December 2020

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

1 reference

12 December 2020

Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted

1 reference

12 December 2020

Degradomics: systems biology of the protease web. Pleiotropic roles of MMPs in cancer

1 reference

12 December 2020

Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment

1 reference

12 December 2020

Molecular balance of capillary tube formation versus regression in wound repair: role of matrix metalloproteinases and their inhibitors

1 reference

12 December 2020

Towards third generation matrix metalloproteinase inhibitors for cancer therapy

1 reference

12 December 2020

Gelatinase A/TIMP-2 imbalance in lymph-node-positive breast carcinomas, as measured by RT-PCR

1 reference

12 December 2020

Matrix metalloproteinases at cancer tumor-host interface

1 reference

12 December 2020

Matrix metalloproteinases in cancer invasion, metastasis and angiogenesis

1 reference

12 December 2020

Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion

1 reference

12 December 2020

Restricted expression of membrane type 1-matrix metalloproteinase by myofibroblasts adjacent to human breast cancer cells

1 reference

12 December 2020